Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Huazhi Rougan Granule in Non-alcoholic Simple Fatty Liver
NCT06188611Phase 4Completed
- Sponsor
- Shandong New Time Pharmaceutical
- Start
- May 2017
- Primary completion
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of huazhi rougan granule in non-alcoholic fatty liver disease (NAFLD), sponsored by Shandong New Time Pharmaceutical. Started May 2017; status: completed.
02
Drugs
huazhi rougan granule
03
Conditions
non-alcoholic fatty liver disease (NAFLD)
Beyond the preview
Go deeper on NCT06188611.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06188611.